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Prolonged periods of sedentary behavior are linked to cardiometabolic disease 
independent of many risk factors including exercise and activity levels. This study 
examined the effects of posture, rather than activity by comparing one full day of sitting 
(14.45 ± 0.286 hours) compared to one full day of standing (12.22 ± 0.105 hours) on 
postprandial metabolism and lipemia. Eighteen subjects aged 23.72 ± 0.795 years 
completed two (sit/stand), four-day trials in a randomized crossover design. The first two 
days of the trial were control days where activity and diet were matched across trials. The 
third day involved one full day of sitting or standing. The fourth day was a high fat 
tolerance test, in which blood and gas samples were collected immediately before and for 
six hours after the ingestion of a high fat shake (1.34, 0.92, 0.17 g/kg body weight of fat, 
carbohydrate, and protein, respectively). Indirect calorimetry was used to measure 
metabolic rate and substrate oxidation while spectrophotometry was used to measure 
plasma concentration. Area under the curve (AUC) for the postprandial responses in 
plasma glucose and triglyceride were calculated with the trapezoidal rule. Prolonged 
 v 
standing resulted in significantly lower plasma triglyceride concentration (p=0.036) and 
an 11.3% decrease in total AUC (p=0.022) compared to sitting, but no change in 
incremental AUC (AUCi) was detected (p=0.186). There were no changes in substrate 
oxidation (p=0.522) or plasma glucose glucose concentration (p=0.776) during the high 
fat tolerance test. The study shows that posture does influence the lipid profile 
independent of exercise or activity by increasing the clearance of triglyceride from the 
blood stream without increasing the oxidation of fat. 
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GENERAL INTRODUCTION 
With the advent of technology in modern times, people find themselves sitting 
more and more. Self-reports show that Americans sit an average of 8 hours per day, while 
objective measurements show that Australian workers sit an average of 69.4 percent of 
waking hours during work days, which would translate to approximately 11.1 hours 
(Patel et al., 2010) (Hadgraft et al., 2016). Although technological advances have brought 
countless benefits to modern day life, it would appear that the increased inactivity 
accompanying this new era is associated with increased mortality risk from all causes, 
particularly cardiovascular disease (Katzmarzyk et al., 2009). Interestingly, meta-analysis 
shows that the negative effects of prolonged sitting appear to be independent of the 
volume of structured exercise, thus suggesting that an individual partaking in extensive 
periods of inactivity may not reduce health detriment with acute bouts of exercise 
(Biswas et al., 2015). Because of this, people that meet ACSM (American College of 
Sports Medicine) guidelines for volume of physical activity may still be putting 
themselves at risk by sitting too much. 
Elevation of blood triglyceride content after eating, known as post-prandial 
lipemia (PPL) is associated with increased risk of cardiovascular disease and mortality 
(Nordestgaard et al., 2007). PPL is believed to attribute to atherosclerosis by depositing 
chylomicron remnants onto arterial walls (Mamo et al., 1998). This has led to the notion 
that post-prandial lipid metabolism may be used as a marker of cardiovascular health and 
has spawned much research into interventions to reduce PPL. Previous studies have 
shown that various forms of exercise, including one hour of running, reduce the PPL 
response after a high fat meal (Trombold et al., 2013) (Kim et al., 2014).  This effect was 
only observed in an active population taking more than 5,000 steps per day. Furthermore, 
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prolonged bouts of inactive sitting not only raise PPL, but it also diminishes the healthy 
effect of acute exercise (Kim et al., 2016). In other words, a person who is engaging in 
the recommended amount of exercise may not be receiving a major exercise-induced 
benefit to cardiometabolic health if they spend too much of their non-exercising time 
seated. There are already many people who do not perform structured exercise, but the 
notion that prolonged sitting may be independently detrimental to PPL is concerning.   
Naturally, one would inquire if the negative effects of prolonged sitting could be 
attenuated by replacing sitting with standing. Although this seems sensible, objective 
measures are needed to determine whether prolonged standing improves lipid metabolism 
before recommendations can be made. In rats, it has been observed that abolishing 
ambulatory activity results in increased PPL and decreased lipoprotein lipase -- an 
enzyme responsible for shuttling plasma triglyceride into muscle cells (Bey & Hamilton, 
2003). Three human studies have compared sitting and standing but have failed to show 
significant reductions in PPL (Miyashita et al., 2013) (Thorp et al., 2014) (Henson et al., 
2016). These studies, however, required subjects to stand and sit in an intermittent 
fashion to break up prolonged sitting, rather than entirely replacing sitting with standing. 
Furthermore, these preliminary studies accumulated only one hour to four-and-a-half 
hours of standing in total. The current study aimed to examine the changes to PPL when 
12 hours of sitting are replaced with 12 hours of standing. 
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Research Purpose and Hypotheses 
This study examines the effect performing one full day of prolonged sitting or 
prolonged standing on PPL during a high fat tolerance test. The specific hypothesis was 
as follows: 




REVIEW OF LITERATURE 
Introduction 
 Cardiovascular disease has not only become responsible for more deaths in the 
United States than any other health event and 17% of health care expenditures as of 2011, 
it is projected to effect 40.5% of Americans by 2030 (Heidenreich et al., 2011). With 
such an ominous forecast, the discovery of new and effective interventions to reduce the 
risk of cardiovascular disease has become paramount. It is clear that exercise is a proven 
method to reduce the risk of cardiovascular disease as well as promote many other health 
benefits (Pate et al., 1995). More recently, however, it has become apparent that 
sedentary behavior may not only mitigate exercise induced health benefits, but it may 
elicit its own independent detriments to health as well (Owen et al., 2010). The average 
level of physical activity of Americans has dropped considerably since 1950 due to 
changes in technology and culture (Brownson et al., 2005), which makes sedentary-
induced health detriments even more concerning. Investigation into the nefarious effects 
that prolonged sitting has on health has led to the development of a new field of study 
deviating from the well-established field of exercise physiology: ‘inactivity physiology’ 
(Hamilton et al., 2007). 
 With the emergence of a new physiological field and a notable increase in 
sedentary activities, a primary goal is to understand the complex interactions between 
sedentary behaviors, body posture, non-exercise physical activity, exercise, and health. 
Through review of epidemiological studies as well as interventional research, one may 
begin to associate the complicated network of interactions between these variables, and 
hopefully apply them to promote better advocacy and practical applications to improve 
the health of many. One such method that may be applied to those affected by the 
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advancement of workplace technology would be replacing seated time with standing 
time. If standing rather than sitting helps to promote health benefits, then it may be 
possible to combat sedentary-induced health detriment without impeding the 




Section I: Sedentary Behavior and Morbidity  
 To understand sedentary behavior, one must first define it. Sedentary behavior has 
been defined by the American Heart Association as activity with an intensity ranging 
between 1 and 1.5 metabolic equivalents. A metabolic equivalent is the energy expended 
while resting in a seated position, which results in an oxygen consumption of 
approximately 3.5 ml of oxygen per kilogram of body weight per minute (Ainsworth et 
al., 2000). The Sedentary Behavior Research Network included body position in its 
definition to describe sedentary activities as “any waking behavior characterized by an 
energy expenditure less than or equal to 1.5 metabolic equivalents while in a sitting or 
reclining posture” (Sedentary.Behaviour.Research.Network, 2012). Many behaviors that 
fall under this category are very common in the American lifestyle including sitting 
during computer use, class work, driving, playing video games, watching television, 
reading, and social conversation.  
 Early inquiry into the effects of sedentary behavior on cardiovascular health was 
primarily epidemiological; the presence of mortality or morbidity due to cardiovascular 
disease gave a clear and dichotomous measurement of cardiovascular health. The first, 
and most classic of these sedentary epidemiological studies, was conducted by Jeremiah 
Morris et al. in 1953; it was discovered that double decker bus drivers incurred a 
significantly higher incidence of myocardial infarction compared to conductors (Morris et 
al., 1953).  A primary difference between the two professions is the amount of time spent 
doing sedentary activity. The bus drivers would spend the vast majority of their day 
seated as they worked, while the conductors were constantly standing, walking, and 
climbing up and down stairs. This iconic study was the first of many epidemiological 
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investigations into the relationship between physical activity and cardiovascular 
morbidity and mortality. 
 The first challenge when setting up an epidemiological study is determining the 
method for quantifying the amount of time spent inactive. Morris introduced the idea by 
using occupation. This provided insight, yet assumed inactivity instead of providing 
measurements. Subsequent studies would utilize self-report assessments from subjects to 
quantify sedentary behavior time. However, as expected, the validity of subjects’ self-
reporting was brought into question. It was found that subjects estimated the time they 
spend in sedentary activity more accurately when it was attached to television viewing, 
compared to a less accurate and low estimation of sedentary time regarding more general 
reports such as time spend performing sedentary behavior in the workplace (Clark et al., 
2011) (Thorp et al., 2012). A later study showed a reduced cardioprotective effect of 
exercise for the same amount of self-reported television viewing compared to self-
reported inactivity (Ekelund et al., 2016). The inconsistency of self-reports for sedentary 
activity compared to television viewing displays a need for more objective measurements 
of activities. Accelerometers have become the common measurement tool for 
physiologists studying inactivity. An accelerometer is a small device that can be worn on 
the waist, wrist, ankle, or leg to measure acceleration. These devices convert movement 
to electrical signals that are summed to quantify total sedentary time (Healy et al., 2011). 
Unfortunately, these devices do not give any context to the activity, so a combination of 
device assessment and self-reporting may be the best combination to paint a true picture. 
 Even with questions regarding the measurement of activity, it seems clear that 
prolonged inactivity poses a burden on cardiovascular health. There is a consistent and 
direct relationship between television viewing time and the presence of cardiovascular 
disease (Ford & Caspersen, 2012). This relationship is also seen with instances of total 
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cardiovascular disease as well as incidence of nonfatal cardiovascular disease and 
coronary heart disease (Stamatakis et al., 2011). Perhaps most interestingly, this 
relationship persists even when controlled for sociodemographic status, obesity, overall 
health, and amount of moderate to vigorous physical activity performed (Chomistek et 
al., 2013). However, the dangers of prolonged periods of sitting do not just stop at 
cardiovascular disease. Individuals who self-report viewing more than 7 hours of 
television a day not only display a doubling in risk of cardiovascular mortality, but they 
also have a 60% greater risk for all-cause mortality and a 20% increase in risk for cancer 
mortality, when adjusted for quantity of moderate to vigorous physical activity 
(Matthews et al., 2012).  
 These epidemiological studies indicate the importance of studying the relationship 
between inactivity and health, but they are reliant on morbidity or death. Because of this, 
they are unable to study the effects of inactivity on health in non-diseased individuals 
prior to morbidity. To better understand sedentary effects before the onset of disease, a 
measurable proxy for in vivo cardiovascular health became necessary, leading to the use 




Section II: Postprandial Lipemia as a Marker of Health 
 The elevation of blood triglyceride concentration after eating is known as post-
prandial lipemia (PPL); it can last for six to eight hours and the degree of this response is 
associated with increased risk of cardiovascular disease and mortality (Nordestgaard et 
al., 2007). PPL is measured by calculating the area under the curve of plasma 
triacylglycerol concentration over the course of 6 to 8 hours post meal ingestion (M. 
Maraki et al., 2011). When measuring PPL, it is common to also collect gas samples; the 
collection of these samples allows one to indirectly calculate fat oxidation (Frayn, 1983). 
As such, a measurement of postprandial fat metabolism through PPL allows insight into 
cardiometabolic health in living, non-diseased people. 
One way that chronically high PPL likely contributes to health is by altering the 
concentration of high density lipoprotein cholesterol; high concentrations of this 
cholesterol are associated with reduced risk of cardiovascular disease (Barter & Rye, 
1996).The concentration of high density lipoprotein cholesterol is highly dependent on 
the body’s ability to metabolize triglyceride rich lipoproteins, especially in the fed state 
(Miesenbock & Patsch, 1992). In postprandial lipemia, chylomicrons accumulate from 
ingested lipids, and these absorbed triglycerides compete with high density lipoprotein 
cholesterol for clearance from the blood through the same pathway in the liver, which is 
mediated by lipoprotein lipase (Bjorkegren et al., 1996). Cholesterol from high density 
lipoprotein is transferred more rapidly to triglyceride rich lipoproteins, thus reducing the 
high density lipoprotein cholesterol concentration and resulting in an increase in small-
dense low density lipoproteins, which are believed to be atherogenic (Griffin, 1997). 
Because of this, the efficiency of one’s body to metabolize fat directly alters this increase 
in small-dense low density lipoproteins, allowing for measurability of a healthy response. 
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PPL may also contribute to cardiovascular disease risk through direct deposition 
of postprandial lipoproteins onto arterial walls, thus causing the buildup of plaque, also 
known as atherosclerosis (Zilversmit, 1979) (Mamo et al., 1998). Further arterial health 
outcomes are observed as ingestion of fat increases blood coagulability through a rise in 
thrombotic plasma factors and induces endothelial dysfunction hours after feeding, which 
is a component of the atherosclerotic process (Vogel et al., 1997) (Miller et al., 1991). 
The relationship between high concentrations of postprandial lipoproteins and 
arterial plaque accumulation is well established (Karpe, 1999). Therefore, it would seem 
reasonable to use meal-induced PPL and the liver output of postprandial lipoproteins and 
triglycerides as a measurable surrogate for cardiometabolic health in research studies.  
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Section III: Effects of Exercise on Postprandial Lipemia 
If physical inactivity is culpable for cardiovascular disease risk, one would 
naturally inquire as to how physical activity may mitigate this risk, especially when 
activity is amplified to the degree of exercise. The use of oral fat tolerance tests to 
measure PPL is now widespread throughout exercise physiology research, and much has 
been elucidated as to the relationship between exercise and PPL. In general, acute 
exercise results in a reduction of PPL, but this is influenced by variables such as oral fat 
tolerance test timing, intensity and volume of exercise, energy expenditure and balance, 
macronutrient content of prior feedings, training status, and prior bouts of prolonged 
sedentary activity. 
If oral fat tolerance tests are to be used in conjunction with exercise for 
comparisons, the first and most obvious question is when to test subjects. Should test 
meals be ingested prior to the exercise bout? After, perhaps? And if so, how long after is 
ideal? 
 When exercise is performed immediately after the ingestion of the test meal 
results are unclear. Some studies show that there is a reduction in PPL after exercise 
compared to control groups, while others show no apparent difference (H. Cohen & 
Goldberg, 1960) (Sady et al., 1986) (Zhang et al., 1998) (Welle, 1984). When no meal is 
given, there is either no change or an increase in the fasting plasma triglyceride 
concentration immediately following a bout of exercise (Thompson et al., 1980) (Dufaux 
et al., 1986). A clear reduction in PPL is present when a test meal is given within one 
hour after a bout of aerobic exercise ranging from 60-70% of maximal oxygen 
consumption for at least 50 minutes (Katsanos et al., 2004) (Plaisance et al., 2008). This 
immediate PPL reducing response is not seen with very low aerobic intensities of 25% 
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VO2max, and with resistance exercise, PPL is exacerbated (Burns et al., 2006; Katsanos 
et al., 2004). These test meals had a high composition of fat, but there appears to be no 
clear PPL response when the test meal has a moderate fat content (Pfeiffer et al., 2005) 
(Cox-York et al., 2013). Many athletes, recreational and competitive, consume meals 
immediately after training sessions, thus denoting the importance of these findings. 
 Reductions in PPL are more clear and robust, however, when the test meal is 
ingested 12 to 24 hours after the bout of exercise where a reduction in PPL is present in 
continuous aerobic exercise, intermittent sprint exercise, intermittent aerobic exercise, 
and resistance exercise (Herd et al., 2001) (Gill et al., 2001) (Freese et al., 2011) (Altena 
et al., 2004) (Zafeiridis et al., 2007). Similar to immediate meal ingestion, this response 
does not occur at very low intensities like slow walking (Tsetsonis & Hardman, 1996a) 
(Petitt et al., 2003). The exercise-induced reduction in PPL disappears sometime between 
24 and 40 hours after the exercise bout (Pafili et al., 2009). Because of the timing of this 
response, and its largest reductions happening hours after exercise, it can be implied that 
exercise may induce some change to fat metabolism different than just altering blood 
flow and substrate ability.  
It is observed that most forms of exercise reduce PPL in oral fat tolerance tests 
conducted the day after exercise, but the magnitude of reduction is not the same across all 
forms, volumes, and intensities. 
When observing continuous aerobic exercise, greater intensities elicit greater 
effects on PPL compared to lower intensities when volume is controlled (Malkova et al., 
1999) (Tsetsonis & Hardman, 1996a). In fact, PPL was not reduced at all when walking 
for 90 minutes or jogging for 30 minutes (Petitt et al., 2003) (Altena et al., 2004). 
Interestingly, when matched for energy expenditure, 180 minutes of walking at 30% 
VO2max causes the same percent reduction in PPL as 90 minutes of running at 60% 
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VO2max (Tsetsonis & Hardman, 1996b). This would imply that energy expenditure is a 
primary variable determining the effectiveness of exercise at reducing PPL and that there 
may be an energy cost threshold which must be reached before protective 
cardiometabolic effects occur.  
However, this is only seen when matching energy costs for low intensity exercise 
compared to moderate intensity exercise. When comparing continuous aerobic exercise 
of moderate intensity (one hour at 50%VO2peak) to high intensity aerobic interval 
exercise (5 minute intervals at 90% VO2peak), the results are not equal even though 
energy expenditure was the same (Trombold et al., 2013). The high intensity aerobic 
interval exercise was significantly more effective at reducing PPL. PPL reductions are 
also seen in sprint interval exercise accumulating in 2 minutes of sprinting over the 
course of 18 minutes, even though the energy expended is lower than continuous aerobic 
exercise studies which did not show an effect (Freese et al., 2011). Therefore, it seems 
that although energy expenditure is an important component in altering PPL in moderate 
intensity exercise and lower, either intensity or the type of exercise – intermittent vs 
continuous – influences the efficacy of exercise-induced PPL reduction when the relative 
work load is very high.  
Energy expenditure is not the same as energy balance. The studies that used 
continuous aerobic exercise did not compensate for the energy expended with increased 
food consumption. Therefore, subjects were in a hypocaloric state, which may be a 
causative factor for PPL reduction independent of the exercise itself. In fact, when energy 
balance is restored after a bout of walking at 50% VO2max, there is no longer a 
protective PPL response, which is present when energy balance remains negative (Burton 
et al., 2008).  
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To further investigate, one group examined the effects of exercise on PPL 
compared to diet-induced energy deficit. Although the exercise and diet involved the 
same amount of caloric deficit, exercise was significantly more effective at reducing PPL 
(Gill & Hardman, 2000). This could be due to several reasons. It is possible that there is a 
caloric deficit threshold, which is higher for diet induced negative energy balance 
compared to exercise. It is also possible that diet and exercise reduce PPL through 
different mechanisms or that energy deficit is only one of several factors contributing to 
exercise induced PPL reduction (M. I. Maraki & Sidossis, 2013).  
As previously discussed, intensity is likely one of those factors, which becomes 
increasingly interesting when paired with caloric balance. Low intensity walking exercise 
reduces PPL when combined with diet compared to walking without energy restriction; 
this walking is normally too low of an intensity to elicit a PPL effect (M. Maraki et al., 
2009) (Tsetsonis & Hardman, 1996a). At these low intensities or with diet alone, an 
energy deficit of approximately 30 kJ/kg body weight was needed for a beneficial 
metabolic response, but a smaller energy deficit was needed for resistance exercise (M. 
Maraki & Sidossis, 2010). Exercise maintains a reduction in PPL at high intensities 
regardless of caloric balance. Four bouts of maximal effort sprint interval exercise 
reduces PPL in the eucaloric state but is attenuated compared to negative energy balance 
(Freese et al., 2011).  
The macronutrient content of energy compensation also likely plays a role in this 
response. When subjects perform a combination of 60 minutes of moderate intensity 
(65% VO2peak) and ten high intensity aerobic intervals (2 minutes at 80%-90% 
VO2peak), PPL is reduced in the eucaloric and hypocaloric states (Trombold et al., 
2014). Interestingly, when the compensation meal contained a high carbohydrate content, 
the response was mitigated, but when the compensation meal contained a low 
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carbohydrate content, the response was the same as exercise without energy 
compensation. Energy balance clearly plays a role in the PPL response, but it appears to 
be less impactful when exercise is of high intensity or when the exerciser maintains a 
negative carbohydrate balance, despite maintaining neutral caloric balance. 
Exercise poses a marked influence on cardiometabolic health, but many of the 
studies discussed describe acute bouts of exercise. Is the benefit of exercise caused only 
by acute bouts, or is there a healthy training effect resulting from chronic adaptation? 
Cross-sectional analysis shows that athletes have a smaller PPL response than sedentary 
subjects, which may lead one to believe that there is a cardiometabolic benefit to long 
term exercise training independent of each individual bouts of exercise (J. C. Cohen et 
al., 1989). This conclusion is questionable, however, because subjects were asked to 
continue their typical training program during the days leading up to the oral fat tolerance 
test. Another study showing similar results asked subjects to abstain from exercise for 12 
to 36 hours before testing (Merrill et al., 1989). It is likely that highly trained athletes 
would exercise unless explicitly asked not to, which makes it possible that their most 
recent training bout was still eliciting effects seen with any acute bout of exercise. This 
would prevent any true insight into the effects of chronic training independent of acute 
exercise.  
The same problem is observed when intervention studies put subjects through 
periods of endurance training and conduct oral fat tolerance tests within 36 hours of the 
most recent exercise bout (Weintraub et al., 1989). When male distance runners were 
asked to refrain from exercise for 14 to 22 days, a subsequent oral fat tolerance test 
resulted in a 40% increase in PPL (Mankowitz et al., 1992). A 35% increase in PPL is 
observed in endurance athletes when exercise is absent for 6.5 days prior to testing 
compared to 15 hours prior (Hardman et al., 1998). Therefore, evidence would suggest 
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that the cardiometabolic health benefits induced by exercise are not enhanced by chronic 
training and require a recent, acute bout of exercise.  
This is not to say that training has absolutely no benefits to the PPL response in 
any way, though. Exercise training increases functional capacity and allows one to 
expend more energy for the same relative intensity compared to untrained individuals. 
Because of this, exercise training will allow one to increase the volume and intensity of 
an individual exercise bout, thus increasing the PPL response indirectly. 
Although these studies show that exercise poses the ability to benefit 
cardiometabolic health, it has been seen that this effect can be dampened, or even 
cancelled when paired with an overly sedentary lifestyle. When observing individuals 
engaging in greater than 35.5 MET-h/week of activity, those who watch television for 
more than 5 hours per day exhibit a significantly higher hazard ratio for cardiovascular 
disease than those who watch 4 hours or fewer (Ekelund et al., 2016). This trend is seen 
not only in these highly active people, but also in all quartiles of physical activity used in 
the meta-analysis including 30, 16, and less than 2.5 MET-h/week. Furthermore, data  has 
shown that when an individual takes approximately 1,650 steps per day and maximizes 
sitting for four days, any PPL reduction from an hour run at 67% of maximal oxygen 
consumption disappears, even when a eucaloric state is induced (Kim et al. 2016). The 
exercise-induced reduction in PPL is restored when activity is increased to 17,000 steps 
per day and sitting is minimized. This effect has been coined ‘Exercise Resistance’, and 
poses many new questions surrounding the effects that sedentary lifestyles may have on 




Section IV: Standing and Postprandial Lipemia 
 Although exercise elicits clear benefits to health, many people choose to not 
partake. For those who would rather not exercise, non-exercise physical activity may still 
benefit them. The United States has decreased employment for active occupations like 
agriculture as the technology and service industry has expanded, thus resulting in 
increased amounts of work time dedicated to sitting rather than physical activity; this has 
decreased occupational energy expenditure by approximately 100 kilocalories per day 
compared to 50 years ago (Church et al., 2011). In fact, objective measurements show 
that a typical Australian worker spends approximately 78.8% of their time at work sitting, 
resulting in 69.4% of their total waking hours in a chair (Hadgraft et al., 2016). 
Therefore, it is imperative to try to find ways to improve cardiometabolic health in 
individuals with low exercise adherence. One such answer may be the use of body 
posture, i.e. standing vs sitting, to break up or replace prolonged bouts of sedentary 
behavior. 
The advancement of accelerometer and inclinometer technology has increased 
battery life and allowed these devices to continuously collect data over several days 
without replacement. This has allowed researchers to measure bouts of sitting, standing, 
and activity objectively in both laboratory and long-term, free-living conditions with 
accuracy (Steeves et al., 2015).  
One free-living study observed 31 individuals over the course of three months 
using an activPAL activity monitor and gave 18 of them a sit/stand desk to use freely; 
they observed a sustained two hour decrease in sitting time for the group given the desks 
and found them to have higher fasting plasma concentrations of high density lipoprotein 
cholesterol (Alkhajah et al., 2012). Another study used cross-sectional analysis to 
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compare 168 different people in their free-living conditions and showed that individuals 
who interrupted prolonged sitting bouts more often showed healthier cardiometabolic 
measurements including body mass index, waist circumference, and fasted plasma 
glucose and triglyceride concentration; this was completely independent of the total 
amount of sitting, exercise, and intensity of the interruptions (Healy et al., 2008). Per this 
finding, the composition and duration of sedentary bouts would appear to be a 
contributing factor to sedentary activity’s cardiometabolic effect. Breaking up the 
prolonged periods of sitting often seen in the workplace may be a simple and effective 
method of incorporating healthier habits in individuals who refuse to exercise, but 
investigation with tighter controls than cross-sectional, free-living analysis is needed to 
confidently propose this idea. 
Several interventional studies have tried to remain relevant to the work 
environment by implementing practical, one-day protocols that could easily be replicated 
in the daily lives of an office worker, while maintaining laboratory controls and crossover 
study designs. When comparing 5 hours of uninterrupted sitting to 5 hours of sitting 
interrupted by 2-minute standing bouts every 20 minutes, there is no clear effect on 
resting plasma triglycerides even though plasma glucose concentration was reduced in 
the hours following ingestion of a test meal (Bailey & Locke, 2015). This observation 
only involved 28 cumulative minutes of standing, however, and used measurements of 
plasma glucose rather than PPL. When the prolonged sitting bout was increased to 7.5 
hours one day and then compared to the same sitting time broken up with 5 minutes of 
standing every 30 minutes, a reduction in plasma glucose is observed, but there was no 
reduction in PPL for the three hours following a standardized breakfast and three hours 
following the same meal for lunch (Henson et al., 2016). It should be noted that the 
subjects in question were all overweight/obese, postmenopausal, dysglycemic women, 
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which very well could have altered responses the protocol could have achieved with a 
non-pathological population. These studies only accrued 28 minutes and 40 minutes of 
standing, respectively, over the course of a one day protocol, which seems trivial in 
comparison to the two hours of reduced sitting seen in the free-living study discussed 
above. Furthermore, although food consumption was recorded, it was not controlled for 
specific energy balance or deficit. A similar study in young, healthy, normolipidemic 
males compared six, 45 minute periods of standing separated by 15 minutes of sitting to 7 
hours of continuous sitting; even though standing time increased to 4.5 hours, there was 
not an apparent change in the PPL response, despite reductions in plasma glucose after an 
oral fat tolerance test of moderate fat content. (Miyashita et al., 2013). Low volume 
walking in the same experiment did, however, elicit a PPL response. Again, food 
consumption was recorded and replicated between all trials but did not control for energy 
deficit or balance, and in this study, the test meal was of moderate fat content.  
As of now, one day interventional studies in laboratories have failed to show the 
benefits of standing that have been observed in longer term free-living, cross-sectional 
investigations. It is possible that single days of increased standing may still be of value, 
however, only if standing time is increased, energy balance is manipulated, or a 
combination of the two.  
Longer-term laboratory interventions are more difficult to implement, but one 
study has explored the effects of standing versus sitting in a controlled laboratory setting 
over the course of five days. Overweight and sedentary Australian workers used a 
sit/stand desk to accomplish office work in the laboratory over the course of two 5-day 
trials in which they continuously sat for 8 hours a day or alternated 30 minute bouts of 
standing and sitting over 8 hours, accumulating to 4 hours per day of standing (Thorp et 
al., 2014). This time, diet was manipulated to induce energy balance every day. Similar to 
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the other interventional studies, there was a reduction in blood glucose with standing, but 
there was not a change in four hour PPL between the two protocols, thus still failing to 
show the standing benefits seen in cross-sectional analysis.  
The discussed interventional studies failed to replicate the PPL benefits that 
would be expected based on the free-living studies, which could be due to several 
reasons. It is possible that the free-living interventions had underlying confounding 
variables with the lack of a controlled laboratory setting. Because the free-living studies 
were cross-sectional as opposed to crossover designs, the lifestyles, hormonal profiles, 
and many other physiological factors relating to the bodies and health of the subjects 
could have simply been different. It is also possible that energy balance plays a key role 
in PPL reduction for an activity with as low of an intensity as standing. Energy 
expenditure is raised by 11.5% when standing continuously for one hour compared to 
sitting (Gibbs et al., 2016). This means that 4 hours of continuous standing would only 
increase energy expenditure by 48 kilocalories in the average American woman and 57 
kilocalories in the average American man (Fryar et al., 2012). With energy expenditure 
so low, it is reasonable to believe that standing may contribute to a healthier 
cardiometabolic response when combined with diet-induced energy deficit. It should also 
be noted that all studies utilized measures to break up prolonged bouts of sitting but did 
not completely replace sitting with standing. It is possible that a PPL reduction may be 
observed when standing is present in more prolonged bouts where accumulative standing 
is greater than 4.5 hours – which was the highest seen in any study – or when standing 





 Cardiometabolic health involves the interplay of many different health variables, 
but it is clear that sedentary activity poses health detriments independent of common 
cardiovascular disease risk factors such as obesity, overall health status, 
sociodemographics, and BMI (Chomistek et al., 2013). By using the PPL response 
following an oral fat tolerance test, researchers are able to investigate these influences 
prior to the induction of a diseased state. Unsurprisingly, exercise has the ability to 
increase cardiometabolic health, but this is influenced by the exercise modality, intensity, 
energy balance and expenditure, macronutrient composition, and even overall sitting 
time. For those who do not want to participate in exercise to increase their health, 
alterations in their body posture pose possible alternatives. Studies that break up 
prolonged sedentary bouts with standing seem beneficial in free-living observational and 
interventional scenarios but are discordant with laboratory interventions regarding lipid 
concentration measurements. With relatively few analyses in this particular area, there is 
a need for further research with greater standing quantities, emphasis on the state of 
energy balance, and the replacement of sitting rather than fragmentation of prolonged 
bouts. 
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STUDY: THE EFFECTS OF PROLONGED STANDING COMPARED 
TO PROLONGED SITTING ON POSTPRANDIAL LIPEMIA  
 
Introduction 
As the industrialized world continues to make technological advancements, the 
amount of time spent engaging in prolonged periods of sitting has vastly increased. 
Epidemiological analysis has pointed to prolonged sitting as a risk factor for 
cardiovascular disease, independent of many other common risk factors(Biswas et al., 
2015). Therefore, interventions that reduce this sedentary time may prove beneficial to 
health. The degree of postprandial lipemia (PPL), or the rise in plasma triglycerides in the 
6 to 8 hours after feeding, is associated with cardiovascular disease and atherosclerosis 
and is consequently often used as a surrogate marker of cardiovascular health in 
research(Nordestgaard et al., 2007). It is established that exercise of many forms induces 
a reduction in PPL(Gill et al., 2001; Herd et al., 2001), but it has recently been found that 
this effect can be nullified by large quantities of prolonged sitting during non-exercising 
waking hours(Kim et al., 2016).  
Because prolonged sitting increases cardiovascular disease risk independently and 
can even prevent health benefits of exercise, it is practical to investigate the effects of 
reducing prolonged sitting. Standing is an attractive alternative to sitting because it would 
not prohibit many of the activities involved with sitting, and could be used for 
populations with low exercise adherence. Several studies have broken up prolonged 
periods of sitting with standing resulting in reductions to blood glucose or insulin, but not 
to PPL(Bailey & Locke, 2015; Henson et al., 2016). This study aimed to completely 
replace one 12 hour day of prolonged sitting with standing, rather than fragmenting these 
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periods. Controlled feeding ensured that energy intake matched resting metabolism. The 
purpose of this design was to utilize increases in PPL to determine if body posture is a 
contributing and manipulative variable that may be altered to incite a healthier response. 
We hypothesized that one day of prolonged standing would reduce PPL compared to one 






Eighteen healthy, recreationally active but untrained, males and females (8 males, 
8 females) aged 23.72 ± 0.795 years completed two different trials in a randomized, 
crossover experimental design. Trials were separated by at least six days. Subjects body 
mass 79.06 ± 4.988 kg, their height was 174 ± 2.805 cm, and their BMI was 25.75 ± 
1.137 kg/m2. One subject displayed both an obese BMI and plasma nutrient 
concentration, but statistical analysis did not gain or lose significance with the obviation 
of this subject’s data. Subjects had no history of cardiovascular or metabolic disease, and 
were all non-smokers. Participants signed their informed consent prior to participation, 
and were informed of all possible risks and procedures involved with the study. This 




The protocol consisted of preliminary testing, followed by two phases that each 
were performed twice: a controlled activity phase of two days, a standing/sitting 
intervention phase of 12 hours on the third day, and a high fat tolerance test phase lasting 
6 hours on the third day. Subjects were asked to refrain from exercise from the start of the 
first controlled activity day to the end of the high fat tolerance test. There was a minimum 





Prior to any trials, each subject came to the laboratory for preliminary testing the 
morning after an 8 hour fast. During this time, subjects sat for 30 minutes, then stood for 
30 minutes; subjects did so while breathing into a meteorological balloon. Samples from 
the balloon were analyzed with a mass spectrometer and volume analyzer so that resting 
and standing metabolic rates can be measured. Metabolic measurements were used to 
determine the caloric content of the provided meals. Subjects’ weight and height were 
measured prior to metabolic testing. Subjects were also asked to complete a health history 
questionnaire and informed consent form prior to any measurements. 
 
Controlled Activity Phase 
The controlled activity phase consisted of the two days prior to the 
sitting/standing intervention. Subjects arrived at the laboratory at approximately 8:00 
hours. They were given a pedometer and were asked to be aware of their step count, and 
to take 5,500-6,500 steps per day, which is concordant to a non-sedentary, low level of 
physical activity (Tudor-Locke & Bassett, 2004). Subjects were also equipped with an 
activPAL activity monitor on a randomly chosen thigh, which was used for the monitor 
across both trials. The activity monitor is a small flat device (approximately 3.3 cm) 
which was secured to the thigh via Tegaderm. It is equipped with both an accelerometer 
and an inclinometer that allows it to measure body position and movement, and estimate 
intensity of activity and energy expenditure. Subjects were asked to eat their normal diet 
and to log everything consumed and the time at which it was consumed into a provided 
food journal; they were also asked to take pictures of the food during the two days. 
Subjects were asked to repeat food consumption exactly during the second controlled 
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activity phase. Subjects recorded the time that they went to sleep, and repeated this 
during the other trials. 
 
Sit/Stand/ Intervention Phase 
On the day of the sit or stand intervention phase, subjects reported to the Human 
Performance Laboratory at 8:00 hours following an eight hour fast. The pedometer was 
removed at this time. They were provided breakfast then asked to stand on a 6 square foot 
cushioned mat or sit in a cushioned chair for 12 hours total – a time frame slightly longer 
than estimates of Australian workers mentioned prior (Hadgraft et al., 2016). Sitting and 
standing were interrupted only for visits to the toilet, but steps were minimized otherwise. 
When standing, the subjects were allowed to lean on the desk holding their screen. Water 
was provided ad libitum. They were provided lunch, a snack, and dinner. Provided food 
contained a macronutrient content of the western variety, containing 59.43% 
carbohydrate, 19.61% protein, and 20.96% fat. The number of calories provided equaled 
their resting metabolic rate estimated from preliminary testing, and was replicated for 
both trials. This induced near energy balance in the sit trial, and slight negative energy 
balance in the stand trial. 
After the 12-hour protocol, subjects were asked to continue wearing the activity 
monitor, and to fast until returning to the laboratory the subsequent morning for an oral 
high fat tolerance test. They were asked to lay down when they return home from the 
laboratory, and to minimize sitting or standing in the time between the intervention and 
the high fat tolerance test the next morning.  
 
 27 
High Fat Tolerance Test Phase 
The morning after the standing/sitting intervention phase, subjects arrived to the 
laboratory to begin the high fat tolerance test phase for measurement of PPL. Upon 
arrival, the activPAL activity monitor and pedometer were removed, followed by 
measurement of body weight. Subjects were then seated comfortably in a chair while a 
catheter was inserted into an antecubital vein. A saline flush was attached to the line and 
flushed every seven minutes to prevent clogging. After five minutes, a fasted blood 
sample was collected in a 6 mL K2 EDTA vacutainer, which was promptly centrifuged at 
3,000 rpm for 15 minutes at 4°C. Plasma was then aliquoted into an Eppendorf safe-lock 
tube, labeled, and stored at -80°C until later analysis. This process was repeated for all 
collected samples.  
Once subjects had remained seated for 20 minutes, they were asked to breathe 
into a meteorological balloon for 10 minutes. This sample was analyzed by a mass 
spectrometer and volume analyzer to measure fat oxidation and metabolic status. 
After the gas sample was taken, subjects were given a high fat shake consisting of 
melted ice cream and heavy whipping cream (1.34 g/kg fat, 0.92, g/kg carbohydrate, and 
0.17 g/kg protein). Subjects were asked to consume the shake within five minutes. After 
completion of the shake, 6 ml of blood were sampled after 1, 2, 3, 4, 5, and 6 hours. To 
measure postprandial fat oxidation and metabolic status, ten minute gas samples were 
also collected after 2, 4, and 6 hours after shake ingestion. Following the 6 hour blood 
and gas sample, subjects were allowed to leave the laboratory.  
Plasma triglyceride and glucose levels were measured enzymatically using 
commercially available diagnostic kits. 
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GENERAL MEASUREMENTS AND INSTRUMENTATION 
Resting/Standing Metabolic Rate 
On the day of preliminary testing, subjects were asked to sit down for 30 minutes 
and then to stand for 30 minutes. During the last ten minutes of sitting and standing 
subjects breathed into a meteorological balloon. Expired air was analyzed with a mass 
spectrometer (Perkin-Elmer MGA 1100, St Louis, Missouri)and a volume analyzer 
(Vacumed, Ventura, CA) to find the sitting and standing metabolic rates of the subject 
through indirect calorimetry. These measurements were used and extrapolated to the 
number of calories provided during the sit/stand intervention phase.  
 
Postprandial Gas Exchange 
During the high fat tolerance test, ten minute gas samples were collected at 
baseline, 2, 4, and 6 hours post shake ingestion. These samples were analyzed with the 
mass spectrometer and volume analyzer to determine fat oxidation and metabolism 
during the test. 
 
Anthropometric Measurements 
Body weight was measured using a (Lifesource UC 321 precision scale); height 
was measured using a physician’s scale. Both were measured prior to preliminary testing 





During the controlled activity phase, diet was logged and replicated by the subject 
during subsequent trials. Diet during the sit/stand intervention day was provided by the 
laboratory. Calories of the diet approximately replicated the subject’s resting metabolic 
rate. This was approximated from the metabolic rates measured during preliminary 
testing. Macronutrient content of the provided food contained 20.96% fat, 59.43% 
carbohydrate, and 19.61% protein. On the day of the high fat tolerance test, subjects were 
provided with a shake consisting of melted ice cream and heavy whipping cream. 
Macronutrient content of the test shake was 1.34, 0.92, 0.17  g/kg body weight of fat, 
carbohydrate, and protein, respectively. This resulted in a caloric content of 15.8 kcal/kg 
body weight (an average of 1249 kcal).  
 
Physical Activity Monitoring 
Subjects wore an activPAL activity monitor (PAL Technologies Limited, 
Glasgow, UK) from the beginning of the controlled activity phase to their arrival at the 
laboratory for the high fat tolerance test. This device has both an accelerometer and an 
inclinometer, and was used to measure body position, and movement, and intensity of 
activity. 
The activPAL also measured the number of steps taken; however, subjects were 
unable to see their step count by this device. Because of this, subjects were also equipped 
with a pedometer (Yamax Digi-walker CW-701) so that the number of steps taken during 
the controlled activity phase could be measured with visual feedback. Subjects were 




Blood Sampling and Preparation 
Subjects were fasted for 12 hours prior to the high fat tolerance test. Blood 
samples were acquired through an antecubital venous catheter. The first sample was 
taken prior to shake ingestion, and 6 subsequent samples were taken each hour after 
shake ingestion..  
Once blood samples were collected, they were centrifuged for 15 minutes at 3,000 
rpm and 4°C. They were then immediately transferred to test tubes and labeled with the 
identification number of the subject. Samples were then stored in a locked laboratory 
freezer at -80°C until further analysis.  
Blood samples were analyzed for plasma triglyceride and glucose concentration 
enzymatically using standardized, commercially-available diagnostic kits (Pointe 
Scientific, Inc. Canton, USA) and a plate reader (Tecan Infinite 200 PRO, Tecan Group 
Ltd., Mannedorf, Switzerland).  
 
Plasma Triglyceride Measurement 
Spectrophotometric methods with commercially available kits and a plate reader 
were used to measure plasma triglyceride concentration. First, plasma samples were 
removed from the -80°C freezer and placed in an ice-water bath to thaw. After thawing, 3 
µL of plasma were removed and added to 300 µL of triglyceride reagent. The 
triglycerides (TG) were hydrolyzed by lipase into glycerol and fatty acids; the glycerol 
was then phosphorylated via ATP into glycerol 3-phosphate (G-3-P) and ADP via 
glycerol kinase (GK). Glycerol 3-phosphate was catalyzed by glycerophosphate oxidase 
(GPO) into dihydroxyacetone phosphate (DHAP) and hydrogen peroxide (H2O2). The 
produced hydrogen peroxide then reacted with 4-aminoantipyrine and 3-hydroxy-2,4,6-
tribomobenzoic (TBHB) to form a red quinoneimine dye in a reaction catalyzed by 
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peroxidase. The dye’s absorbance was then spectrophotometrically measured at 480 nm. 
The produced color’s intensity is directly proportional to the triglyceride concentration of 
the sample. Chemical Reactions for this process can be seen in Figure 2. 
 
Plasma Glucose Measurement 
Spectrophotometric methods with commercially available kits (Pointe Scientific, 
Inc. Canton, USA) and a plate reader were used to measure plasma glucose 
concentration. First, plasma samples were removed from the -80°C freezer and placed in 
an ice-water bath to thaw. After thawing, 5µL of plasma were removed and added to 
1,000 µL of glucose reagent, which was then incubated for 3 minutes at room 
temperature. The glucose was phosphorylated with ATP, thus producing glucose 6-
phosphate (G-6-P) in a reaction that is catalyzed by hexokinase (HK). Glucose 6-
phosphate dehydrogenase (G6PDH) then catalyzed a reaction in which glucose 6-
phosphate is oxidized and NAD is reduced to form NADH, 6-phosphogluconate, and H+. 
NADH absorbance was measured at 340 nm. The NADH concentration is directly 
proportional to the sample plasma glucose concentration. Chemical Reactions for this 
process can be seen in Figure 3. 
 
Proposed Statistical Analysis 
 Total and incremental areas under the curve for plasma triglyceride and glucose 
concentration were calculated using the trapezium rule. Total postprandial substrate 
oxidation of carbohydrate and fat, total standing time, total sitting time, daily step 
numbers, caloric intake, sitting and standing metabolic rate, and fasting plasma 
concentration of triglycerides and glucose were analyzed using paired samples T-tests. 
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Postprandial absolute and relative substrate oxidation, and concentrations of plasma 
triglyceride and glucose were analyzed using two-way ANOVA with repeated measures 
(trials and time). When interactions were significant, Bonferroni multiple comparisons 
analyses were conducted. Data were analyzed using Graphpad Prism software (Graphpad 
Software, San Diego, CA). Data are presented as means and standard error. The level of 





Changes in Body Mass 
Subject body weight during preliminary testing, the sitting intervention’s high fat 
tolerance test (HFTTsit), and the standing intervention’s high fat tolerance test 
(HFTTstand) was 79.06 ± 21.08, 78.76 ± 21.27, and 79.02 ± 21.13 kg, respectively. 
There were no significant differences in body weight between the three trials (p=0.752). 
Energy Intake 
Caloric intake did not change during the sitting and standing intervention days 
(2131 ± 427.4 kcal/day), as the same food was provided during both trials to match 
estimated resting metabolism (2118 ±  426.5 kcal/day) found through preliminary testing. 
During the standing intervention subjects ate 85.58 ± 120.9 fewer kcals than their 
estimated metabolic rate with 12 hours of standing (2216 ± 500 kcal/day). Taller subjects 
had greater differences in energy balance on the standing intervention day; there was a 
significant correlation between height and the difference between estimated sitting and 
standing metabolism (r=0.784, p <0.0001).   
Steps and Posture Distribution 
 There was no significant difference in the number of steps that participants took 
on control days for the sitting trial compared to those for the standing trial (p>0.05). 
Likewise, there was no significant difference in the number of steps that participants took 
on the intervention day for the sitting trial compared to those for the standing trial 
(p>0.05) (Figure 4; Table 5). There was no significant difference in the amount of time 
that participants spent standing on control days for the sitting trial compared to those for 
the standing trial (p>0.05) (Figure 5; Table 6). 
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 All measurements of sitting, standing, and stepping on the day of the sit/stand 
intervention include the entirety of the day, not just the time spent in the laboratory. 
There was no significant difference in steps taken between the sitting or standing 
intervention day (p>0.05) (Figure 4). As expected, subjects sat significantly more during 
the sitting trial (p<0.001) and stood significantly more during the standing trial (p<0.001) 
(Figure 6). There was no significant difference in time spent stepping between the two 
trials (p>0.05). 
Postprandial Metabolism 
 Indirect calorimetry was used for all measurements of substrate oxidation and 
metabolic rate. All subjects that displayed a respiratory exchange ratio greater than 1 at 
any point of the tolerance test were eliminated from gas analysis to control for 
hyperventilating subjects. Relative fat oxidation includes the percentage of energy 
derived from fat, relative to carbohydrate. There was no significant difference between 
trials in relative fat oxidation (p>0.05) (Figure 7) or in absolute fat oxidation, (p>0.05) 
(Figure 8). When only examining postprandial values after baseline, there was no 
significant difference in fat oxidation between trials (p>0.05); when only examining 
fasted baseline values, there was no significant difference in fat oxidation between trials 
(p>0.05). 
 When comparing baseline and postprandial samples there was no significant 
difference in metabolic rate between the sitting or standing high fat tolerance test 
(p>0.05) (Figure 9). However, when only examining the postprandial response there was 
a significant effect of posture on metabolic rate between the sitting and standing trials 
(p=0.032) (Figure 10). When only examining fasted values, there was no significant 
difference in metabolic rate found between the trials (p>0.05).  
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 Plasma Concentrations 
 After calculating the area under the curve (AUC) using the trapezoidal rule, the 
HFTTstand total AUC for plasma triglyceride was significantly lower than the HFTTsit 
total AUC for plasma triglyceride (p=0.022) resulting in an 11.3% decrease in total AUC, 
but it was not significantly higher when comparing plasma triglyceride incremental AUC 
(AUCi) (p>0.05) (Figures 12 and 13). Plasma triglyceride concentrations displayed a 
significant time effect over the course of the HFTTs (p<0.001), as well as a significant 
posture effect (p=0.036), (Figure 11). There was no significant difference in fasted 
plasma triglyceride concentration between the trials (p>0.05). 
 For plasma glucose, there was no significant difference in total AUC (p>0.05), 
and there was also no significant difference in AUCi between trials (p>0.05) (Figures 15 
and 16). There was a significant main effect of time on plasma glucose (p<0.001), but no 
significant main effect of posture (p>0.05) (Figure 14). Likewise, the intervention did not 





The primary finding of this study is that one full day of prolonged standing 
reduces the rise in plasma triglyceride concentration compared to one full day of 
prolonged sitting. Interestingly, although the total response was reduced, the plasma 
triglyceride concentration was not statistically different in the fasted state or the four 
hours after test meal ingestion. The prolonged standing induced a decrease in plasma 
triglyceride in the fifth and sixth hour after the meal. Prolonged standing also led to a 
decrease in postprandial energy expenditure compared to sitting by a marginal 31.78 ± 
44.73 kcal over the six hours of the tolerance test. No other metabolic markers including 
plasma glucose concentration, metabolic rate, percent of kcal from fat, or fat oxidation. 
 Prolonged sedentary activity across a range of time frames has shown to lead to a 
negative effect on postprandial metabolism by increasing plasma triglyceride 
concentration. It was found that one month of bed rest increases plasma triglyceride in 
the fasted and the postprandial state (Bergouignan et al., 2006; Bergouignan et al., 2009). 
Later, it was discovered that postprandial triglycerides can increase after two weeks of 
sedentary activity, even though subjects lost lean and total body mass, indicating an 
independence from positive energy balance (Olsen et al., 2008). Further reducing the 
sedentary time, Kim et al showed that plasma triglyceride can increase compared to an 
active (16,000 steps/day) baseline high fat tolerance test after just two days of prolonged 
sitting by reducing steps to 2000 steps/day (Kim et al., 2016). In this study, four total 
days of sedentary activity was enough to increase postprandial lipemia despite an hour of 
moderate intensity exercise, or a 628 kcal deficit the day prior to the high fat tolerance 
test.  There was also no difference between sedentary individuals on a hypercaloric or 
eucaloric diet. This is observed despite the multitude of studies linking exercise bouts to 
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improved postprandial lipid profiles (Altena et al., 2004; Gill et al., 2001; Malkova et al., 
1999) (Herd et al., 2001). Because the four days elicited no change in mass, it is likely 
that the postprandial responses following inactivity studies can be linked to the inactivity 
itself, rather than a loss of muscle mass inducing decreased muscle metabolic function. 
 With the evidence of sedentary-induced detriments to postprandial metabolism, 
one may wonder if the cause is simply a lack of contraction and activity over the 
prolonged period of time, or if it is the posture itself and the act of sitting down that alters 
postprandial lipemia. This study tries to illuminate the answer by utilizing prolonged 
standing. Subjects did not take a significantly different number of steps between the 
sitting or standing trials, thus showing changes independent of actual movement. 
Furthermore, subjects spent 85.58 ± 120.9 kcal more when standing which is below the 
range of 200-250 kcal – the lowest amount of energy expenditure needed to observe 
changes in postprandial lipemia (Miyashita, 2008; Miyashita et al., 2008). Only four 
subjects spent over 200 kcal more in the standing day than the sitting day; interestingly, 
all four of which are at least 185 cm tall. With a significant correlation between height 
and the difference between sitting and standing metabolic rate (p<.0001), it should be 
noted that taller people may gain some benefit to postprandial metabolism through energy 
expenditure as well as posture when standing for prolonged periods of time. With little 
movement and energy expenditure, observations in this study focus on the metabolic 
effects of posture rather than changes to the well-studied exercise-induced benefits.  
The present study shows that prolonged standing does decrease the total area 
under the curve of a high fat tolerance test, but not the incremental area under the curve 
or any measure of fat oxidation. Incremental area under the curve is often used in 
postprandial metabolic research because of its accuracy in describing the postprandial 
triglyceride response to an oral fat load, while total area under the curve is descriptive of 
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the total lipid profile rather than the postprandial response alone, and more dependent on 
the fasted triglyceride while incremental is not at all (Carstensen et al., 2003).  
Incremental area under the curve only includes the area above baseline, so it is possible to 
have a smaller incremental area under the curve between two tolerance test responses, 
even if the peak plasma triglyceride concentration is the same, because a higher baseline 
would reduce the area above that baseline. Therefore, it would appear that prolonged 
standing does not reduce the lipemic response following feeding per se, but does induce a 
reduced overall lipid profile. In other words, prolonged standing did not reduce the post-
feeding rise from a fasted triglyceride concentration, but it does attenuate the overall 
concentration of triglycerides before and after feeding. 
 There were no changes in relative or absolute fat oxidation, yet triglyceride 
concentration decreased with prolonged standing; this would suggest that triglyceride is 
not leaving the blood stream because of increased use of triglyceride for energy. 
Intracellular triglyceride is stored in adipose and muscle tissue to be used for energy 
when needed, and is transported from the blood stream to these tissues with the aid of 
lipase enzymes (Oscai et al., 1990; Zimmermann et al., 2004). It is possible that 
prolonged standing enhances a component of the storing capacity of these tissues, thus 
increasing the clearance of triglyceride from the blood without oxidizing it. 
 By nature of the study, it is difficult to illuminate the mechanisms responsible for 
the observed response to prolonged standing. There are, however, several speculative 
connections can be made. Although not directly measured in this study, it is possible that 
there is an increase in the function or activity of a lipase responsible for triglyceride 
clearance. Lipoprotein lipase is the rate limiting lipase responsible for the clearance of 
chylomicron triglycerides and very low density lipoprotein triglyceride in muscle (Wang 
& Eckel, 2009), and is known to decrease in the presence of sedentary behavior (Bey & 
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Hamilton, 2003). Muscle lipoprotein lipase is primarily found in slow oxidative muscle 
fibers, and reaches its highest levels with low intensity ambulatory activity the activation 
of postural muscles in rats (Hamilton et al., 1998). It is possible that the inactivation of 
postural muscles that accompanies prolonged sitting could lead to reduced muscle 
lipoprotein lipase activity relative to the prolonged standing, and impair the clearance of 
triglyceride from the blood to muscle for storage 
 Lipoprotein lipase is produced in subendothelial parenchymal cells before 
translocating and binding to the endothelium of capillaries distributed throughout muscle, 
heart, and adipose tissue (Braun & Severson, 1992). The enzyme’s activity can be tissue 
specific (Semb & Olivecrona, 1986), so it may be possible that changes in blood flow and 
shear stress to lower extremity muscles may alter the activity of lipoprotein lipase in the 
surrounding capillaries. Prolonged periods of sitting can result in impaired vascular 
function in the lower extremities due to reductions in shear stress (Restaino et al., 2016). 
Although it is yet to be shown, it is possible that lower extremity endothelial dysfunction 
and reduced muscle lipoprotein lipase activity are the nexus to a decrease in plasma 
triglyceride seen in prolonged standing. 
 Others may point to insulin as the causative factor for response observed in the 
study, but it is not possible to be certain because insulin was not measured in this study. It 
has been shown, however, that two days of sedentary activity with a hypercaloric diet can 
reduce whole body insulin sensitivity compared to an active and eucalorically fed group 
(Kim et al., 2016). In this study, the insulin explained 28% of the variation in 
postprandial triglyceride. Because sedentary-induced insulin resistance is limited to the 
area of the inactive muscle, it is possible that the full day of prolonged sitting in the 
present study reduced the insulin sensitivity of lower extremity muscles (Krogh-Madsen 
et al., 2010). If this is true, then excess nutrients may be unable to enter resistant muscle 
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tissue and instead be transported to the liver to be assembled into very low density 
lipoproteins (Petersen et al., 2007). It should be noted however, that there were no 
changes in glucose or fat oxidation, which are measures directly impacted by insulin. 
Even then, localized insulin resistance may not be shown through the calculation of 
insulin resistance because systemic plasma glucose and insulin may not be reflective of 
the lower extremity muscle, only (Seider et al., 1982). 
 The present study is not without limitations. Because insulin and lipoprotein 
lipase were not directly measured, it is difficult to know what mechanism is responsible 
for metabolic responses observed in the study. Because taller subjects exhibited a higher 
rate of energy expenditure, it is possible that taller subjects had some level of metabolic 
perturbation caused by spending more calories that would be alleviated with a more 
homogenous subject height. Some subjects experienced shifting pressures at work and in 
their lives, which prevented complete replication of control day steps. However, there 
was not a statistically significant difference and the standing trial is the one that displayed 
a lower step count on the second control day, which would effectively bias results against 
what was observed for standing if it did cause any change. Because subjects did not come 
in to the laboratory for a period to familiarize themselves with the procedures of 
obtaining gas samples, some hyperventilated resulting in an abnormally high respiratory 
exchange ratio. Although statistical analysis of gas samples obviated hyperventilating 
subjects, some may have been overfed on their intervention day as a result of this. 
Finally, one subject was obese and displayed fasted plasma triglyceride and glucose 
concentrations consistent with obesity, however, no statistical analysis performed gained 
or lost significance with the removal of this subject’s data. 
 To conclude, the data show that a full day of prolonged standing does not alter the 
postprandial response to feeding, but does attenuate the total triglyceride lipid profile 
 41 
compared to a day of prolonged sitting. Furthermore, prolonged standing does not induce 
a change in plasma glucose, relative or absolute fat oxidation. The findings of the study 
would suggest that posture does have an influence over metabolism independent of 
movement or activity.  
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Weight (kg) Height (cm) BMI 
Sub 2  67.4 167.64 
 
23.983 
Sub 3  72.1 172.72 
 
24.169 
Sub 4  70.91 156 
 
29.138 
Sub 5  65.42 167.64 
 
23.279 
Sub 6  67.15 167.64 
 
23.894 
Sub 7  94.85 175.26 
 
30.88 
Sub 8  56.8 152.92 
 
24.29 
Sub 9  66.75 162.56 
 
25.259 
Sub 10  91.2 187.96 
 
25.815 
Sub 11  59.9 170.18 
 
20.683 
Sub 12  71.3 185 
 
20.833 
Sub 13  127.27 200.66 
 
31.609 
Sub 14  54.85 172.72 
 
18.386 
Sub 15  75.7 180.34 
 
23.276 
Sub 16  74 170.18 
 
25.551 
Sub 17  79.55 182.88 
 
23.785 
Sub 18  104.3 187.96 
 
29.523 
Sub 19  123.55 177.8 
 
39.082 
Mean  79.06 174.3 
 
25.75 
SEM  ± 4.988 ± 2.805 
 
± 1.137 
Weight, height, and BMI of subjects collected during preliminary testing 




   
Seated Metabolic 












































































































































Metabolic rates were measured through indirect calorimetry. Measurements were extrapolated to estimate full day 
metabolism . *denotes a significant difference from the seated metabolic rate (p=0.0011) 















































































































































































































































































































Contents of food fed to subjects on their sitting/standing intervention day 




Weight kg Calories Fat g Sat Fat g CHO g PRO g g/kg fat 
Sub 2 Sit 67.4 
 
1168.8 89.856 51.416 84 16 1.3332 
Sub 3 Sit 72.1 
 
1225.2 96.624 55.364 84 16 1.3401 
Sub 4 Sit 70.91 
 
1130.92 94.110 55.5644 72 12 1.3272 
Sub 5 Sit 65.42 
 
1065.04 86.205 50.9528 72 12 1.3177 
Sub 6 Sit 67.15 
 
1165.8 89.496 51.206 84 16 1.3328 
Sub 7 Sit 94.85 
 
1418.2 129.384 74.474 64 12 1.3641 
Sub 8 Sit 56.8 
 
1041.6 74.592 42.512 84 16 1.3132 
Sub 9 Sit 66.61 
 
1079.32 88.7184 50.7524 64 12 1.3319 
Sub 10 Sit 91 
 
1372 123.04 72.44 72 12 1.3521 
Sub 11 Sit 59 
 
988 76.96 45.56 72 12 1.3044 
Sub 12 Sit 71.3 
 
1135.6 95.472 54.692 64 12 1.3390 
Sub 13 Sit 127.27 
 
1807.24 176.069 101.7068 64 12 1.3834 
Sub 14 Sit 54.85 
 
938.2 71.784 40.874 64 12 1.3087 
Sub 15 Sit 74.7 
 
1176.4 100.368 57.548 64 12 1.3436 
Sub 16 Sit 74 
 
1248 99.36 56.96 84 16 1.3427 
Sub 17 Sit 78.6 
 
1223.2 105.184 62.024 72 12 1.3382 
Sub 18 Sit 104.3 
 
1531.6 142.192 83.612 72 12 1.3633 
Sub 19 Sit 123.55 
 
1762.6 169.912 99.782 72 12 1.3752 
Sub 2 Stand 67.85 
 
1174.2 90.504 51.794 84 16 1.3339 
Sub 3 Stand 71.95 
 
1223.4 96.408 55.238 84 16 1.3399 
Sub 4 Stand 70.91 
 
1130.92 94.1104 55.5644 72 12 1.3272 
Sub 5 Stand 65.9 
 
1070.8 86.896 51.356 72 12 1.3186 
Sub 6 Stand 68.65 
 
1183.8 91.656 52.466 84 16 1.3351 
Sub 7 Stand 85.8 
 
1309.6 116.352 66.872 64 12 1.3561 
Sub 8 Stand 57.5 
 
1050 75.6 43.1 84 16 1.3148 
Sub 9 Stand 66.75 
 
1081 88.92 50.87 64 12 1.3321 
Sub 10 Stand 91.2 
 
1374.4 123.328 72.608 72 12 1.3523 
Sub 11 Stand 59.9 
 
998.8 78.256 46.316 72 12 1.3064 
Sub 12 Stand 71.35 
 
1136.2 95.544 54.734 64 12 1.3391 
Sub 13 Stand 128.95 
 
1827.4 178.488 103.118 64 12 1.3842 
Sub 14 Stand 55.65 
 
947.8 72.936 41.546 64 12 1.3106 
Sub 15 Stand 75.7 
 
1188.4 101.808 58.388 64 12 1.3449 
Sub 16 Stand 74.65 
 
1248 99.36 56.96 84 16 1.3310 
Sub 17 Stand 79.55 
 
1234.6 106.552 62.822 72 12 1.3394 
Sub 18 Stand 106.1 
 
1553.2 144.784 85.124 72 12 1.3646 
Sub 19 Stand 124.1 
 
1769.2 170.704 100.244 72 12 1.3755 
Mean 78.95 
 
1249 106.2 61.57 72.67 13.11 1.339 
SEM ±3.487 
 





Contents of the test meal ingested during the HFTT 



























9052 7002 2538 




6738 4918 1822 




8516 10242 2494 




7378 3622 4142 




5204 9148 6818 




6980 9040 4510 




8550 8434 1122 




8910 7662 1490 




18588 4238 4488 




5760 6982 654 




4096 1976 1986 




7270 7414 2954 




6402 3698 6180 




9514 7952 2074 




4312 5238 6836 




7914 5314 6294 




9107 8516 4772 




7630 3634 2756 




7885 6391 3552 














Steps Taken during the two control days as well as the intervention day. There was no significant difference  in 
the number of steps taken between sit/stand control days (p=0.117) or sit/stand intervention days (p=0.053). 




















Sub 2 2.438 2.43 0.52 4.59 3.11 12.26 
Sub 3 3.692 4.43 0.99 1.886 5.69 11.7 
Sub 4 4.186 6.64 1.43 3.266 2.23 12.29 
Sub 5 1.397 2.97 1.174 2.689 1.97 13.12 
Sub 6 1.639 4.953 0.675 7.06 1.61 12.07 
Sub 7 1.73 2.628 1.08 2.71 4.57 13.36 
Sub 8 2.736 2.021 0.698 3.679 5.9 12.16 
Sub 9 6.467 2.97 0.909 2.184 6.14 12.35 
Sub 10 1.614 2.73 0.843 2.37 1.29 12.21 
Sub 11 2.05 2.83 0.54 1.698 3.99 12.14 
Sub 12 1.127 1.72 0.91 2.097 3.71 12.21 
Sub 13 1.774 1.74 1 1.0975 2.5 12.25 
Sub 14 0.79 1.9 0.9867 0.916 2.41 11.47 
Sub 15 2.151 2.03 0.67 2.352 1.68 11.69 
Sub 16 2.8 2.74 0.62 2.214 4.77 12.19 
Sub 17 1.707 1.18 0.664 1.959 1.02 12.085 
Sub 18 1.83 1.74 0.48 1.121 1.18 12.08 
Sub 19 2.19 1.78 0.477 1.64 1.05 12.36 
Mean 2.351 2.746 0.8148 2.529 3.046 *12.22 








Time spent standing during the two control days as well as the intervention day. There were no significant differences  
in standing time between sit/stand control days (p=0.379). (*) Significantly greater time spent standing compared to 
the time spent standing on the sit intervention day (p<0.001) 
 


















Sub 2 13.515 2.74333 0.82 12.26 0.3 0.48 
Sub 3 13.455 1.1 0.99 11.7 0.42 0.47 
Sub 4 15.12 2.588 1.43 12.29 1.028 0.467 
Sub 5 13.325 0.8567 1.174 13.12 0.397 0.96 
Sub 6 13.11 0.845 0.675 12.07 0.626 1.13 
Sub 7 16.297 3.95 1.08 13.36 0.338 1.01 
Sub 8 12.84 1.31 0.698 12.16 0.178 0.171 
Sub 9 14.78 1.087 0.909 12.35 0.282 0.2 
Sub 10 15.25 3.86 0.843 12.21 0.44 0.85 
Sub 11 16.27 2.55 0.54 12.14 1.32 0.19 
Sub 12 15.62 2.27 0.91 12.21 0.47 0.52 
Sub 13 13.35 3.45 1 12.25 0.65 0.64 
Sub 14 13.32 3.757 0.9867 11.47 0.557 1.17 
Sub 15 14.22 1.82 0.67 11.69 0.51 0.49 
Sub 16 13.31 1.322 0.62 12.19 1.07 1.22 
Sub 17 14.668 3.61 0.664 12.085 0.23 1.28 
Sub 18 15.203 3.477 0.48 12.08 0.35 1.01 
Sub 19 16.405 1.408 0.477 12.36 0.37 0.53 
Mean 14.45 *2.334 0.8315 #12.22 0.5298 0.7104 










Table 7 Intervention Day Posture (hours) 
Time spent sitting, standing, or stepping on the day of intervention. (*) Significant difference in sitting time  between trials 




Sit BL Sit H2 Sit H4 Sit H6 Stand BL Stand H2 Stand H4 Stand H6 
Sub 2 68.181 82.105 75.800 73.518 72.55 81.645 76.010 79.893 
Sub 3 85.436 95.297 96.744 105.904 93.457 97.035 94.863 95.792 
Sub 5 70.149 72.892 75.207 72.179 71.476 76.006 71.483 70.514 
Sub 8 67.465 77.420 71.429 78.834 61.669 76.817 71.752 70.37 
Sub 9 92.442 101.71 96.136 94.868 96.841 73.031 97.663 90.479 
Sub 11 64.274 79.668 77.512 67.830 65.013 83.176 54.616 57.324 
Sub 12 93.672 105.914 95.829 98.659 92.079 112.871 103.704 103.960 
Sub 13 109.69 139.918 129.839 132.263 112.544 123.174 123.236 119.212 
Sub 14 67.439 86.135 78.453 81.272 69.397 78.988 75.204 76.553 
Sub 15 74.408 94.96 93.218 87.100 77.358 96.793 84.017 98.08 
Sub 17 84.754 98.156 97.061 100.158 83.239 86.502 95.713 88.987 
Sub 19 89.688 111.202 108.153 104.621 84.052 84.805 87.084 89.926 
Mean 80.63 95.45 91.28 91.43 81.64 89.24 86.28 86.76 















Metabolic rate during the HFTT, measured through indirect calorimetry 




Sit BL Sit H2 Sit H4 Sit H6 Stand BL Stand H2 Stand H4 Stand H6 
Sub 2 48.402 49.105 82.273 80.345 56.011 36.725 58.620 72.881 
Sub 3 71.630 35.543 72.895 74.310 77.378 59.232 85.267 87.919 
Sub 5 79.649 54.898 55.442 76.590 62.250 57.895 63.116 71.660 
Sub 8 33.943 42.545 66.721 85.875 52.854 35.151 47.046 70.654 
Sub 9 67.882 55.008 83.113 79.521 83.181 58.058 71.651 80.767 
Sub 11 29.098 31.455 33.286 54.847 56.613 30.173 62.069 19.704 
Sub 12 68.702 52.156 88.477 89.112 68.840 86.233 100 100 
Sub 13 76.57 46.264 98.545 100 86.151 72.519 100 100 
Sub 14 64.24 58.717 79.589 85.826 83.580 49.097 84.076 89.444 
Sub 15 70.594 76.66 100 100 73.92 62.054 76.353 76.639 
Sub 17 100 89.383 100 100 66.448 71.651 93.275 100 
Sub 19 41.825 69.281 70.136 88.481 77.83 98.195 100 100 
Mean 62.71 55.08 77.54 84.58 70.42 59.75 78.46 80.81 




Sit BL  Sit H2 Sit H4 Sit H6 Stand BL Stand H2 Stand H4 Stand H6 
Sub 2 33.001 40.318 62.363 59.068 40.636 29.984 44.557 58.227 
Sub 3 61.198 33.871 70.521 78.698 72.316 57.476 80.888 84.219 
Sub 5 55.873 40.016 41.696 55.282 44.494 44.004 45.117 50.530 
Sub 8 22.900 32.938 47.658 67.699 32.595 27.002 33.757 49.721 
Sub 9 62.752 55.952 79.902 75.440 80.553 42.400 69.977 73.077 
Sub 11 18.702 25.060 25.801 37.203 36.806 25.097 33.899 11.295 
Sub 12 64.355 55.241 84.787 87.917 63.388 97.332 103.704 103.96 
Sub 13 83.998 64.732 127.952 132.263 96.958 89.325 123.236 119.21 
Sub 14 43.326 50.576 62.440 69.753 58.003 38.780 63.228 68.472 
Sub 15 52.527 72.796 93.218 87.100 57.190 60.064 64.149 75.172 
Sub 17 84.754 87.735 97.060 100.158 55.310 61.979 89.277 88.987 
Sub 19 37.513 77.043 75.854 92.571 65.417 83.274 87.084 89.926 
Mean 51.74 53.02 72.44 78.6 58.64 54.73 69.91 72.73 




Relative and absolute fat oxidation during the HFTT, measured through indirect calorimetry. % energy from fat is relative to % 
energy from carbohydrate. 
Table 9b HFTT Absolute Fat Oxidation (kcal/hour) 






Sub 2 462.848 475.099 
Sub 3 595.892 575.383 
Sub 5 440.557 436.008 
Sub 8 455.367 437.884 
Sub 9 585.443 522.347 
Sub 11 450.022 390.233 
Sub 12 600.807 641.071 
Sub 13 804.044 731.247 
Sub 14 491.724 461.490 
Sub 15 550.558 557.793 
Sub 17 590.750 542.406 
Sub 19 647.955 523.631 
Mean 556.3 *524.5 
SEM ±30.55 ±27.54 
Postprandial energy expenditure measured after the ingestion of the test meal during the HFTT. (*) Significantly greater 
postprandial energy expenditure during the HFTTstand compared to HFTTsit (p=0.032). 
Table 10 HFTT Postprandial Energy Expenditure (kcal/6h) 
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Sit BL Sit H1 Sit H2 Sit H3 Sit H4 Sit H5 Sit H6 
Sub 2 0.6800 1.1306 1.2042 1.7411 1.0107 1.0441 0.8236 
Sub 3 0.7251 1.1228 1.8569 2.3232 2.6615 2.5508 2.3668 
Sub 4 1.7400 2.0010 2.0903 2.3706 2.3866 1.9717 1.3939 
Sub 5 1.7338 2.2832 3.0414 2.7715 3.1355 2.3725 2.0238 
Sub 6 0.8655 0.8008 1.2226 1.1994 1.2341 0.7332 0.8548 
Sub 7 0.8333 1.2643 2.4142 2.6549 2.1256 1.4717 1.2494 
Sub 8 1.1168 1.2472 1.9119 1.6300 1.6046 1.4983 1.4674 
Sub 9 2.0120 2.1526 2.4402 2.4750 2.6234 2.5130 2.2216 
Sub 10 0.8455 1.2340 1.7901 1.6969 1.5168 1.4485 1.2182 
Sub 11 0.9659 1.2177 1.1159 1.4241 1.5808 1.1403 0.9568 
Sub 12 0.8208 0.8535 1.3021 2.2022 2.6912 1.9628 1.4365 
Sub 13 0.8637 1.0839 1.5799 1.8910 1.7910 1.8308 1.2803 
Sub 14 0.7922 1.2502 2.2888 2.1708 1.8038 1.3931 1.1810 
Sub 15 0.9888 1.1903 2.2135 3.7133 5.3204 4.9714 3.7811 
Sub 16 1.3364 1.6260 2.6527 2.6293 2.7961 2.9844 2.7406 
Sub 17 0.6224 1.0211 1.6090 1.9035 2.0230 1.5259 1.3705 
Sub 18 1.1517 1.6341 2.6904 2.9723 3.5127 2.9921 3.2556 
Sub 19 2.3783 2.4778 2.9510 3.4231 4.5513 4.7275 5.7789 
Mean 1.137 1.422 2.021 2.289 2.465 2.174 1.967 




Stand BL Stand H1 Stand H2 Stand H3 Stand H4 Stand H5 Stand H6 
Sub 2 0.8917 1.4488 1.1982 1.2140 1.6090 1.4345 0.9169 
Sub 3 1.0048 1.1531 1.8262 1.9566 2.0303 2.1403 1.6284 
Sub 4 1.1043 1.4117 1.8641 1.9981 2.0368 1.4646 1.2604 
Sub 5 1.5397 1.7413 2.2885 2.4599 2.1776 1.7830 1.8522 
Sub 6 0.8491 0.8775 1.3008 1.4619 1.3220 0.7747 0.7154 
Sub 7 0.5370 0.6805 1.1186 1.5595 1.4310 1.0115 1.2599 
Sub 8 0.9432 1.1437 1.4674 1.6007 1.2673 1.3210 1.1789 
Sub 9 1.6856 2.0394 2.0494 2.5733 2.3270 1.8548 1.7639 
Sub 10 0.7235 0.9162 1.5226 1.5182 1.5126 1.0143 0.9207 
Sub 11 1.0490 1.2775 1.3259 1.2989 1.8177 1.0181 0.8193 
Sub 12 0.7249 0.8687 1.8194 2.5207 2.6054 2.2429 1.8408 
Sub 13 0.7849 1.1789 2.4484 2.4635 2.3522 1.8620 1.1088 
Sub 14 0.6580 0.8474 2.1255 2.0066 1.7642 1.4427 1.2560 
Sub 15 1.5520 1.9718 1.2919 1.9244 2.5230 2.1672 1.3428 
Sub 16 0.8699 1.1666 1.7838 2.9511 3.3458 3.5577 2.9950 
Sub 17 0.7123 1.0512 1.9453 2.3846 1.7549 1.4309 1.1702 
Sub 18 0.8785 1.2105 2.5162 3.5511 4.1318 3.3761 3.5044 
Sub 19 2.0115 2.1977 2.5263 2.7624 3.4016 3.2062 3.7325 
Mean 1.029 1.288 1.801 2.123 2.19 1.839 1.626 











Plasma triglyceride concentration in mM throughout the HFTT. (*) Significantl effect of posture on plasma triglyceride 
concentration between the two trials (time p>.001, Intervention p=0.036).  
Table 11a Sit Triglyceride (mM) 




Sit Total AUC Stand Total AUC Sit AUCi Stand AUCi 
Sub 2 6.8824 7.8096 2.8020 2.4586 
Sub 3 12.0616 10.4240 7.7102 4.3944 
Sub 4 12.3891 9.9576 4.0239 3.3316 
Sub 5 15.4836 12.1520 5.0810 2.9081 
Sub 6 6.0511 6.5198 1.6511 2.2271 
Sub 7 10.9729 6.6994 5.9721 3.4773 
Sub 8 9.1840 7.8615 2.4835 2.2023 
Sub 9 14.3204 12.5698 2.2486 2.4552 
Sub 10 8.7187 7.3059 3.6456 2.9646 
Sub 11 7.4403 7.6729 1.6455 2.7568 
Sub 12 10.1406 11.3388 5.2154 6.9908 
Sub 13 9.2484 11.2519 4.0668 6.5424 
Sub 14 9.8932 9.1433 5.1397 5.1962 
Sub 15 19.7978 11.3275 13.8573 3.5744 
Sub 16 14.7269 14.7382 6.7084 9.5183 
Sub 17 9.0790 9.5081 5.3442 5.2346 
Sub 18 16.0031 16.9744 9.0948 11.7115 
Sub 19 22.2146 16.9631 7.9394 4.8969 
Mean 11.92 *10.57 5.257 4.602 




Plasma triglyceride total and incremental AUC from the HFTT. (*) standing total AUC is significantly lower than 
sitting (p=0.022) There is no significant difference between incremental areas under the curve (p=0.186) 
Table 12. Triglyceride Total and Incremental AUC (mMx6h) 
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Table 13a Sit Glucose 
 
Sit BL  Sit H1 Sit H2 Sit H3 Sit H4 Sit H5 Sit H6 
Sub 2 3.5013 4.2368 4.9248 5.4478 5.5457 5.5540 4.0186 
Sub 3 5.0626 3.9411 6.8046 6.8235 6.1874 7.4263 7.2625 
Sub 4 4.9785 6.1302 4.8038 5.4191 5.6212 6.1985 4.6883 
Sub 5 5.6023 5.7422 9.2564 6.6492 7.3558 6.4854 5.5130 
Sub 6 6.5249 4.2988 5.5773 6.6015 6.8318 5.5226 5.1687 
Sub 7 5.5316 6.2473 6.8490 7.9414 7.1848 6.0453 6.4283 
Sub 9 5.0454 8.8512 7.0477 5.9420 6.3583 6.1346 5.7489 
Sub 10 5.5796 5.1739 6.9278 7.5612 6.3583 6.2418 5.4206 
Sub 11 5.1246 5.5796 7.4307 6.0447 5.7994 5.0514 4.8524 
Sub 12 5.8498 5.1714 5.7989 6.8520 7.1219 7.3917 5.9408 
Sub 13 5.4668 5.4413 5.9381 5.7405 5.6068 5.8726 5.3458 
Sub 14 5.7688 6.6886 7.5412 7.8781 6.4083 5.9393 6.1091 
Sub 15 4.8567 5.3246 5.0199 7.4202 7.8909 8.7192 5.7184 
Sub 16 5.2885 5.4762 6.9495 6.2062 6.4166 6.4960 6.2495 
Sub 17 5.9781 6.2756 5.6045 8.5231 8.2528 7.3530 6.8696 
Sub 18 4.9224 5.4477 7.7316 6.7325 6.2817 6.7835 7.5068 
Sub 19 5.9393 6.5005 8.5049 9.5981 10.9796 10.8393 11.0506 
Mean 5.354 5.678 6.63 6.905 6.835 6.709 6.111 
SEM ±0.1595 ±0.2742 ±0.3074 ±0.2754 ±0.321 ±0.3356 ±0.3785 
 
 
Table 13b. Stand Glucose 
 
Stand BL Stand H1 Stand H2 Stand H3 Stand H4 Stand H5 Stand H6 
Sub 2 5.6467 6.4105 5.0871 3.4817 6.2035 6.3522 4.5905 
Sub 3 5.3137 6.4999 6.3378 5.5773 6.0369 7.2687 5.6534 
Sub 4 5.7516 4.5668 4.8661 6.2790 6.9417 6.6181 5.5027 
Sub 5 6.0047 5.9870 7.5467 7.6300 7.2109 6.5715 5.7661 
Sub 6 4.9037 6.0153 5.5912 5.9293 6.5904 5.7083 4.9567 
Sub 7 4.8372 4.8813 6.5615 6.8868 5.8932 5.9737 5.901 
Sub 9 5.6750 7.1021 10.4764 7.8148 7.6017 6.9251 5.7294 
Sub 10 4.6193 4.0189 5.6817 5.9215 6.6592 5.3268 4.618 
Sub 11 4.4996 5.4109 4.4981 5.1114 5.4566 5.0215 4.0788 
Sub 12 5.7650 5.1930 6.5760 7.8635 8.1950 7.0987 5.6956 
Sub 13 5.5796 5.1851 6.0808 7.5789 6.8779 6.7136 5.2073 
Sub 14 4.3726 5.1385 6.8174 5.9870 5.3325 6.6675 5.2783 
Sub 15 4.8950 4.6426 6.2079 9.5400 9.8002 8.7192 5.7184 
Sub 16 4.4267 4.3331 5.3791 7.8437 7.8920 8.6919 6.9162 
Sub 17 6.0863 6.8590 6.5348 8.9955 8.1118 7.1549 6.7313 
Sub 18 5.7022 5.8643 5.824 8.9378 7.8415 8.9566 9.5134 
Sub 19 5.9346 6.9646 7.5320 6.9167 6.3252 6.9983 5.9326 
Mean 5.295 5.593 6.329 6.959 6.998 6.869 5.752 
SD ±0.1448 ±0.2329 ±0.3308 ±0.378 ±0.2787 ±0.2701 ±0.2919 
 
      
  





Sit Total AUC 
Stand Total 
AUC Sit AUCi Stand AUCi 
Sub 2 29.46892 32.65505 8.45934 4.089791 
Sub 3 37.34543 37.20666 8.5315 5.322057 
Sub 4 33.00475 34.89755 3.263285 4.254648 
Sub 5 41.04778 40.8313 7.443553 4.891874 
Sub 6 34.68107 34.76433 4.93184 5.342595 
Sub 7 40.24847 35.56364 7.060551 6.544332 
Sub 9 39.73225 45.6216 9.458475 11.57331 
Sub 10 37.76174 32.22764 4.815829 5.328163 
Sub 11 34.892 29.79086 4.499436 2.978531 
Sub 12 38.23355 40.65923 4.542732 6.877377 
Sub 13 34.00388 37.82835 1.259465 5.012325 
Sub 14 40.39279 34.76989 5.783879 8.5315 
Sub 15 39.66009 44.21726 10.52422 15.14244 
Sub 16 37.31213 39.80996 5.584052 13.3551 
Sub 17 42.43547 44.06739 6.821869 7.549017 
Sub 18 39.19383 45.03322 9.658302 10.81841 
Sub 19 54.9191 40.67033 19.2833 5.062837 
Mean 38.49 38.27 7.172 7.216 
SEM 1.232 1.105 0.9081 0.8022 
Table 14. Glucose Total and Incremental AUC (mMx6h) 
Total and Incremental areas under the curve for plasma glucose during the HFTT. No significant difference was found 












Figure 2. Chemical reactions used to spectrophotometrically measure plasma 
triglyceride concentration 
Figure 1. Experimental Design 























Figure 4. Steps taken during the two control days (averaged) and the intervention day. There was no 
significant difference in the number of steps that participants took on control days for the 
sitting trial compared to those for the standing trial (p>0.05). Likewise, there was no 
significant difference in the number of steps that participants took on the intervention 



































Figure 5. Time spent standing during the two control days (averaged) and intervention days. There 
was no difference in standing time during the control days between the sitting or the 
standing trial. (*) Significantly greater time spent standing on the standing 






















Figure 6.  Time spent sitting, standing, and stepping during the intervention day. (*) 
Significantly greater time sitting compared to the stand trial (p<.001). (#) 
Significantly greater time standing compared to the sit trial. There was no 
difference in time spent stepping between the sit and stand trials (p>0.05). 
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Figure 7. Relative fat oxidation during the HFTT. There was not a significant difference 
percentage of energy coming from fat between the two trials (p>0.05). 
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Figure 8. Absolute fat oxidation during the HFTT. There was no significant difference in fat 
oxidation between trials (p>0.05). 
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Figure 9.  Metabolic rate measured by indirect calorimetry during the HFTT. There was no 








































Figure 10. Measurements of postprandial energy expenditure during the HFTT. (*) Significantly 
greater postprandial energy expenditure compared to the standing trial (p=0.032). 
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Figure 11. Plasma triglyceride concentration (mM) over the course of the HFTT was significantly lower in 
the standing trial compared to the sitting trial. (*) Significantly lower plasma triglyceride 









































Figure 12. Total area under (AUC) the curve for plasma triglyceride during the high fat 
tolerance test. (*) Significantly lower total AUC for plasma triglyceride 

































Figure 13. Incremental area under the curve (AUCi) for plasma triglyceride during the HFTT. There 
was no significant difference in AUCi for plasma triglyceride concentration over the 
course of the high fat tolerance test compared to sitting (p>0.05). 
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Figure 14. Plasma glucose concentration (mM) during the high fat tolerance test. There was no 

































Figure 15. Total AUC for plasma glucose during the high fat tolerance test. There was no 
significant difference in AUC for plasma glucose concentration over the 





























Figure 16. AUCi for plasma glucose during the high fat tolerance test. There was no significant 
difference in AUCi for plasma glucose concentration over the course of the high fat 
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